Results 111 to 120 of about 10,401 (200)

Esofagite Eosinofílica [PDF]

open access: yes, 2009
A esofagite eosinofílica constitui uma doença infl amatória do esófago, mundialmente emergente, caracterizada pela infiltração significativa e isolada da mucosa esofágica por eosinófilos.
Gaspar, A, Piedade, S
core  

Eosinophile Ösophagitis: Die Sicht des Gastroenterologen [PDF]

open access: yes, 2018
Zusammenfassung: Die eosinophile Ösophagitis ist charakterisiert durch Symptome ösophagealer Dysfunktion (meist Dysphagie) und eosinophile Entzündungsinfiltrate im Ösophagus.
Schoepfer, A.
core  

Bronchial thermoplasty: implementing best practice in the era of cost containment. [PDF]

open access: yes, 2017
Increasing dependence on advanced technologies in the 21st century has created a dilemma between the practice and business of medicine. From information technology to robotic surgery, new technologies have expanded treatment possibilities and have ...
Kenyon, Nicholas   +3 more
core  

A real-world study to evaluate effectiveness of mepolizumab in treating severe asthma in Taiwan (REMIT)

open access: yesTherapeutic Advances in Respiratory Disease
Background: REMIT is the first real-world study of mepolizumab effectiveness in patients with severe asthma (SA) in Taiwan. Objectives: The primary objective evaluated changes in clinically significant exacerbations (CSEs; defined as use of oral ...
Shih-Lung Cheng   +19 more
doaj   +1 more source

Mepolizumab for the management of chronic rhinosinusitis with nasal polyps across the United States: A retrospective study

open access: yesJournal of Allergy and Clinical Immunology: Global
Background: Retrospective data are limited on the effectiveness of mepolizumab treatment that is reflective of real-world practice in patients with chronic rhinosinusitis with nasal polyps (CRSwNP).
Juan Carlos Cardet, MD, MPH   +10 more
doaj   +1 more source

Care pathways for the selection of a biologic in severe asthma [PDF]

open access: yes, 2017
Bousquet, Jean   +12 more
core   +2 more sources

Mepolizumab-Related Blood Eosinophil Decreases Are Associated with Clinical Remission in Severe Asthmatic Patients: A Real-World Study

open access: yesAntibodies
Background: Mepolizumab is an effective treatment for severe eosinophilic asthma, leading to a depletion of blood eosinophil levels, the clinical relevance of which remains unclear.
Matteo Bonato   +5 more
doaj   +1 more source

When sequential use of mepolizumab and dupilumab in a severe atopic eosinophilic asthmatic questions the role of eosinophils in mediating the clinical expression of the disease: a case report

open access: yesJournal of Medical Case Reports
Background The advent of biologics has resulted in major progress in the treatment of severe T2 high asthmatics. There are currently several classes of biologics approved for severe asthma including anti-immunoglobulin E, anti-interleukin-5/interleukin ...
M. Sabbe   +3 more
doaj   +1 more source

The Effectiveness of Biological Agents on Chronic Rhinosinusitis with Nasal Polyposis in Patients with Comorbid Asthma: A Multicenter Real-Life Study from Türkiye

open access: yesMedicina
Background and Objectives: Real-life data on the efficacy of biologic agents (BAs) on asthma-comorbid CRSwNP are needed. Our primary goal is to investigate the effects of BAs on CRSwNP symptoms, as well as endoscopic and tomography scores.
Meryem Demir   +17 more
doaj   +1 more source

Severe eosinophilic asthma: from the pathogenic role of interleukin-5 to the therapeutic action of mepolizumab

open access: yesDrug Design, Development and Therapy, 2017
Corrado Pelaia,1 Alessandro Vatrella,2 Maria Teresa Busceti,1 Luca Gallelli,3 Rosa Terracciano,3 Rocco Savino,3 Girolamo Pelaia1 1Department of Medical and Surgical Sciences, Section of Respiratory Diseases, University “Magna Græcia&rdquo ...
Pelaia C   +6 more
doaj  

Home - About - Disclaimer - Privacy